PharmaFluidics develops micro-chip chromatography technology, notably the µPAC™ column series, for use in biomarker, diagnostics and drug R&D within the biotech and pharma industries. The company is a VUB spin-off led by Managing Director Johan Devenyns and is based in Ghent, Belgium. Its µPAC™ products are used by academic labs and bio-pharmaceuticals and diagnostics companies across Europe, the USA and Asia. The µPAC™ began commercial shipments in September 2017. PharmaFluidics intends to use newly raised funds to further develop its Pillar Array technology platform, expand the µPAC™ product range, and scale up production and global sales. The articles do not disclose revenue or other operating metrics.

Total raised

$9M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2018